Skip to main content
Erschienen in: Acta Neuropathologica 6/2005

01.12.2005 | Review

Molecular genetic alterations in gliomatosis cerebri: What can we learn about the origin and course of the disease?

verfasst von: Christian Mawrin

Erschienen in: Acta Neuropathologica | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Gliomatosis cerebri (GC) is a neuroepithelial neoplasm with extensive infiltration of large parts of the brain. Recent data showing the involvement of TP53 mutation or nuclear protein accumulation in some cases have linked the astrocytic phenotype of the tumor cells to TP53 alterations frequently found in common astrocytomas. However, the frequency of these alterations is low, and other molecular genetic changes have been only rarely identified. Those found in common high-grade astrocytomas and glioblastomas are usually missing in GC. The distribution of TP53 point mutations, as well as non-coding polymorphic markers and some cytogenetic data, support a monoclonal origin in some cases, and are at least compatible with it in most cases, while no conclusive data suggesting a polyclonal origin have been reported. This raises the question of mechanisms responsible for the enhanced infiltrative potential of the tumor cells in this disease, which have not yet been identified.
Literatur
1.
Zurück zum Zitat Ariza A, Lopez D, Mate JL, Isamat M, Musulen E, Pujol M, Ley A, Navas-Palacios JJ (1995) Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26:1144–1147CrossRefPubMed Ariza A, Lopez D, Mate JL, Isamat M, Musulen E, Pujol M, Ley A, Navas-Palacios JJ (1995) Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26:1144–1147CrossRefPubMed
2.
Zurück zum Zitat Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G (1985) Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 4:135–148PubMed Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G (1985) Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 4:135–148PubMed
3.
Zurück zum Zitat Asher R, Bignami A (1992) Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203:80–90CrossRefPubMed Asher R, Bignami A (1992) Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203:80–90CrossRefPubMed
4.
Zurück zum Zitat Balko MG, Blisard KS, Samaha FJ (1992) Oligodendroglial gliomatosis cerebri. Hum Pathol 23:706–707CrossRefPubMed Balko MG, Blisard KS, Samaha FJ (1992) Oligodendroglial gliomatosis cerebri. Hum Pathol 23:706–707CrossRefPubMed
5.
Zurück zum Zitat Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M, Knyazeva T, Muller S, Gartner S, Sures I, Wang H, Imyanitov E, Haring HU, Knayzev P, Iacobelli S, Hofler H, Ullrich A (2002) Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62:840–847PubMed Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M, Knyazeva T, Muller S, Gartner S, Sures I, Wang H, Imyanitov E, Haring HU, Knayzev P, Iacobelli S, Hofler H, Ullrich A (2002) Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62:840–847PubMed
6.
Zurück zum Zitat Benjelloun A, Delavelle J, Lazeyras F, Dietrich PY (2001) Possible efficacy of temozolomide in a patient with gliomatosis cerebri. Neurology 57:1932–1933PubMed Benjelloun A, Delavelle J, Lazeyras F, Dietrich PY (2001) Possible efficacy of temozolomide in a patient with gliomatosis cerebri. Neurology 57:1932–1933PubMed
7.
Zurück zum Zitat Burke D, Wilkes D, Blundell TL, Malcolm S (1998) Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23:59–62CrossRefPubMed Burke D, Wilkes D, Blundell TL, Malcolm S (1998) Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23:59–62CrossRefPubMed
8.
Zurück zum Zitat Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479CrossRefPubMed Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479CrossRefPubMed
9.
Zurück zum Zitat Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM (1997) Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3:227–230CrossRefPubMed Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM (1997) Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3:227–230CrossRefPubMed
10.
Zurück zum Zitat Cavenee WK, Furnari FB, Nagane M, Huang HJS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P (2000) Astrocytic tumours. In: Kleihues P, Cavenee WK (eds) Pathology and genetics: Tumours of the Nervous System. IARC Press, Lyon, pp 9–39 Cavenee WK, Furnari FB, Nagane M, Huang HJS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P (2000) Astrocytic tumours. In: Kleihues P, Cavenee WK (eds) Pathology and genetics: Tumours of the Nervous System. IARC Press, Lyon, pp 9–39
11.
Zurück zum Zitat Cervos-Navarro J, Artigas J, Aruffo C, Iglesias J (1987) The fine structure of gliomatosis cerebri. Virchows Arch [A] 411:93–98 Cervos-Navarro J, Artigas J, Aruffo C, Iglesias J (1987) The fine structure of gliomatosis cerebri. Virchows Arch [A] 411:93–98
12.
Zurück zum Zitat Cummings TJ, Hulette CM, Longee DC, Bottom KS, McLendon RE, Chu CT (1999) Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol 18:190–197PubMed Cummings TJ, Hulette CM, Longee DC, Bottom KS, McLendon RE, Chu CT (1999) Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol 18:190–197PubMed
13.
Zurück zum Zitat Elshaikh MA, Stevens GH, Peereboom DM, Cohen BH, Prayson RA, Lee SY, Barnett GH, Suh JH (2002) Gliomatosis cerebri. Cancer 95:2027–2031CrossRefPubMed Elshaikh MA, Stevens GH, Peereboom DM, Cohen BH, Prayson RA, Lee SY, Barnett GH, Suh JH (2002) Gliomatosis cerebri. Cancer 95:2027–2031CrossRefPubMed
14.
Zurück zum Zitat Foerster O, Gagel O (1934) Zentrale diffuse Schwannose bei Recklinghausenscher Krankheit. Z Gesamte Neurol Psychiatr 151:1–16 Foerster O, Gagel O (1934) Zentrale diffuse Schwannose bei Recklinghausenscher Krankheit. Z Gesamte Neurol Psychiatr 151:1–16
15.
Zurück zum Zitat Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva JP, Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ (2003) Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 98:269–276PubMed Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva JP, Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ (2003) Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 98:269–276PubMed
16.
Zurück zum Zitat Gutowski NJ, Gomez-Anson B, Torpey N, Revesz T, Miller D, Rudge P (1999) Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology 41:650–653CrossRefPubMed Gutowski NJ, Gomez-Anson B, Torpey N, Revesz T, Miller D, Rudge P (1999) Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology 41:650–653CrossRefPubMed
17.
Zurück zum Zitat Hecht BK, Turc-Carel C, Chatel M, Lonjon M, Roche JL, Gioanni J, Hecht F, Gaudray P (1995) Chromosomes in gliomatosis cerebri. Genes Chromosomes Cancer 14:149–153PubMed Hecht BK, Turc-Carel C, Chatel M, Lonjon M, Roche JL, Gioanni J, Hecht F, Gaudray P (1995) Chromosomes in gliomatosis cerebri. Genes Chromosomes Cancer 14:149–153PubMed
18.
Zurück zum Zitat Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M (2002) Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52:390–399CrossRefPubMed Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M (2002) Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52:390–399CrossRefPubMed
19.
Zurück zum Zitat Horst E, Micke O, Romppainen ML, Pyhtinen J, Paulus W, Schafer U, Rube C, Willich N (2000) Radiation therapy approach in gliomatosis cerebri—case reports and literature review. Acta Oncol 39:747–751CrossRefPubMed Horst E, Micke O, Romppainen ML, Pyhtinen J, Paulus W, Schafer U, Rube C, Willich N (2000) Radiation therapy approach in gliomatosis cerebri—case reports and literature review. Acta Oncol 39:747–751CrossRefPubMed
20.
Zurück zum Zitat Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD (1995) Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37–45PubMed Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD (1995) Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37–45PubMed
21.
Zurück zum Zitat Jezequel P, Campion L, Joalland MP, Millour M, Dravet F, Classe JM, Delecroix V, Deporte R, Fumoleau P, Ricolleau G (2004) G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br J Cancer 90:189–193CrossRefPubMed Jezequel P, Campion L, Joalland MP, Millour M, Dravet F, Classe JM, Delecroix V, Deporte R, Fumoleau P, Ricolleau G (2004) G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br J Cancer 90:189–193CrossRefPubMed
22.
Zurück zum Zitat Kannuki S, Hirose T, Horiguchi H, Kageji T, Nagahiro S (1998) Gliomatosis cerebri with secondary glioblastoma formation: report of two cases. Brain Tumor Pathol 15:111–116PubMed Kannuki S, Hirose T, Horiguchi H, Kageji T, Nagahiro S (1998) Gliomatosis cerebri with secondary glioblastoma formation: report of two cases. Brain Tumor Pathol 15:111–116PubMed
23.
Zurück zum Zitat Kattar MM, Kupsky WJ, Shimoyama RK, Vo TD, Olson MW, Bargar GR, Sarkar FH (1997) Clonal analysis of gliomas. Hum Pathol 28:1166–1179CrossRefPubMed Kattar MM, Kupsky WJ, Shimoyama RK, Vo TD, Olson MW, Bargar GR, Sarkar FH (1997) Clonal analysis of gliomas. Hum Pathol 28:1166–1179CrossRefPubMed
24.
Zurück zum Zitat Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, Choi KS, Cho BK (1998) Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien) 140:755–762 Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, Choi KS, Cho BK (1998) Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien) 140:755–762
25.
Zurück zum Zitat Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H, Dietzmann K (1999) Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes Chromosomes Cancer 26:80–83CrossRefPubMed Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H, Dietzmann K (1999) Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes Chromosomes Cancer 26:80–83CrossRefPubMed
26.
Zurück zum Zitat Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93:534–538CrossRefPubMed Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93:534–538CrossRefPubMed
27.
Zurück zum Zitat Kirches E, Mawrin C, Schneider-Stock R, Krause G, Scherlach C, Dietzmann K (2003) Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri. J Neurooncol 61:1–5CrossRefPubMed Kirches E, Mawrin C, Schneider-Stock R, Krause G, Scherlach C, Dietzmann K (2003) Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri. J Neurooncol 61:1–5CrossRefPubMed
28.
Zurück zum Zitat Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology 1:44–51 Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology 1:44–51
29.
Zurück zum Zitat Kros JM, Zheng P, Dinjens WN, Alers JC (2002) Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61:806–814PubMed Kros JM, Zheng P, Dinjens WN, Alers JC (2002) Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61:806–814PubMed
30.
Zurück zum Zitat Kunishio K, Okada M, Matsumoto Y, Nagao S (2003) Matrix metalloproteinase-2 and −9 expression in astrocytic tumors. Brain Tumor Pathol 20:39–45PubMed Kunishio K, Okada M, Matsumoto Y, Nagao S (2003) Matrix metalloproteinase-2 and −9 expression in astrocytic tumors. Brain Tumor Pathol 20:39–45PubMed
31.
Zurück zum Zitat Kuppner MC, Van Meir E, Gauthier T, Hamou MF, Tribolet N de (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50:572–577PubMed Kuppner MC, Van Meir E, Gauthier T, Hamou MF, Tribolet N de (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50:572–577PubMed
32.
Zurück zum Zitat Lantos PL, Bruner JM (2000) Gliomatosis cerebri. In: Kleihues P, Cavenee WK (eds) Pathology and genetics: Tumours of the Nervous System. IARC Press, Lyon, pp 92–93 Lantos PL, Bruner JM (2000) Gliomatosis cerebri. In: Kleihues P, Cavenee WK (eds) Pathology and genetics: Tumours of the Nervous System. IARC Press, Lyon, pp 92–93
33.
Zurück zum Zitat Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98:2430–2439CrossRefPubMed Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98:2430–2439CrossRefPubMed
34.
Zurück zum Zitat Levin N, Gomori JM, Siegal T (2004) Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology 63:354–356PubMed Levin N, Gomori JM, Siegal T (2004) Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology 63:354–356PubMed
35.
Zurück zum Zitat Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231–234CrossRefPubMed Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231–234CrossRefPubMed
36.
Zurück zum Zitat Lodi R, Setola E, Tonon C, Ambrosetto P, Franceschi E, Crino L, Barbiroli B, Cortelli P (2003) Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. Magn Reson Imaging 21:1003–1007CrossRefPubMed Lodi R, Setola E, Tonon C, Ambrosetto P, Franceschi E, Crino L, Barbiroli B, Cortelli P (2003) Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. Magn Reson Imaging 21:1003–1007CrossRefPubMed
37.
Zurück zum Zitat Mawrin C, Aumann V, Kirches E, Schneider-Stock R, Scherlach C, Vogel S, Mittler U, Dietzmann K (2001) Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55:11–17CrossRefPubMed Mawrin C, Aumann V, Kirches E, Schneider-Stock R, Scherlach C, Vogel S, Mittler U, Dietzmann K (2001) Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55:11–17CrossRefPubMed
38.
Zurück zum Zitat Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, Deimling A von, Landeghem F van, Meyermann R, Bornemann A, Müller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K (2003) Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol 105:529–536PubMed Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, Deimling A von, Landeghem F van, Meyermann R, Bornemann A, Müller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K (2003) Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol 105:529–536PubMed
39.
Zurück zum Zitat Mawrin C, Lins H, Kirches E, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann K (2003) Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34:102–106CrossRefPubMed Mawrin C, Lins H, Kirches E, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann K (2003) Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34:102–106CrossRefPubMed
40.
Zurück zum Zitat Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, Deimling A von, Stoltenburg-Didinger G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K (2005) Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol 72:115–122CrossRefPubMed Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, Deimling A von, Stoltenburg-Didinger G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K (2005) Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol 72:115–122CrossRefPubMed
41.
Zurück zum Zitat Mawrin C, Schneider T, Firsching R, Wiedemann FR, Dietzmann K, Bornemann A, Romeike B, Sellhaus B, Deimling A von (2005) Assessment of tumor cell invasion factors in gliomatosis cerebri. J Neurooncol 73:109–115CrossRefPubMed Mawrin C, Schneider T, Firsching R, Wiedemann FR, Dietzmann K, Bornemann A, Romeike B, Sellhaus B, Deimling A von (2005) Assessment of tumor cell invasion factors in gliomatosis cerebri. J Neurooncol 73:109–115CrossRefPubMed
42.
Zurück zum Zitat Morimoto Y, Ozaki T, Ouchida M, Umehara N, Ohata N, Yoshida A, Shimizu K, Inoue H (2003) Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 98:2245–2250CrossRefPubMed Morimoto Y, Ozaki T, Ouchida M, Umehara N, Ohata N, Yoshida A, Shimizu K, Inoue H (2003) Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 98:2245–2250CrossRefPubMed
43.
Zurück zum Zitat Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS (1995) Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82:858–863PubMed Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS (1995) Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82:858–863PubMed
44.
Zurück zum Zitat Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298–307PubMed Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298–307PubMed
45.
Zurück zum Zitat Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51:6202–6205PubMed Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res 51:6202–6205PubMed
46.
Zurück zum Zitat Oz B, Karayel FA, Gazio NL, Ozlen F, Balci K (2000) The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 6:118–124PubMed Oz B, Karayel FA, Gazio NL, Ozlen F, Balci K (2000) The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 6:118–124PubMed
47.
Zurück zum Zitat Piva R, Cavalla P, Bortolotto S, Cordera S, Richiardi P, Schiffer D (1997) p27/kip1 expression in human astrocytic gliomas. Neurosci Lett 234:127–130CrossRefPubMed Piva R, Cavalla P, Bortolotto S, Cordera S, Richiardi P, Schiffer D (1997) p27/kip1 expression in human astrocytic gliomas. Neurosci Lett 234:127–130CrossRefPubMed
48.
Zurück zum Zitat Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM, Sidransky D (2001) Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015–7019PubMed Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM, Sidransky D (2001) Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015–7019PubMed
49.
Zurück zum Zitat Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY (2004) Initial chemotherapy in gliomatosis cerebri. Neurology 63:270–275PubMed Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY (2004) Initial chemotherapy in gliomatosis cerebri. Neurology 63:270–275PubMed
50.
Zurück zum Zitat Scheinker IM, Evans JP (1943) Diffuse cerebral glioblastosis. J Neuropathol Exp Neurol 2:78–189 Scheinker IM, Evans JP (1943) Diffuse cerebral glioblastosis. J Neuropathol Exp Neurol 2:78–189
51.
Zurück zum Zitat Scherer HJ (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40:159–197 Scherer HJ (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40:159–197
52.
Zurück zum Zitat Schober R, Mai JK, Volk B, Wechsler W (1991) Gliomatosis cerebri: bioptical approach and neuropathological verification. Acta Neurochir (Wien) 113:131–137 Schober R, Mai JK, Volk B, Wechsler W (1991) Gliomatosis cerebri: bioptical approach and neuropathological verification. Acta Neurochir (Wien) 113:131–137
53.
Zurück zum Zitat Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847CrossRefPubMed Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847CrossRefPubMed
54.
Zurück zum Zitat Streit S, Bange J, Fichtner A, Ihrler S, Issing W, Ullrich A (2004) Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int J Cancer 111:213–217CrossRefPubMed Streit S, Bange J, Fichtner A, Ihrler S, Issing W, Ullrich A (2004) Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int J Cancer 111:213–217CrossRefPubMed
55.
Zurück zum Zitat Tancredi A, Mangiola A, Guiducci A, Peciarolo A, Ottaviano P (2000) Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien) 142:469–472 Tancredi A, Mangiola A, Guiducci A, Peciarolo A, Ottaviano P (2000) Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien) 142:469–472
56.
Zurück zum Zitat Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684–689PubMed Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684–689PubMed
57.
Zurück zum Zitat Von Deimling A, Eibl RH, Ohgaki H (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytomas. Cancer Res 52:2987–2990PubMed Von Deimling A, Eibl RH, Ohgaki H (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytomas. Cancer Res 52:2987–2990PubMed
58.
Zurück zum Zitat Von Deimling A, Ammon K von, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19–26PubMed Von Deimling A, Ammon K von, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19–26PubMed
59.
Zurück zum Zitat Yamada SM, Hayashi Y, Takahashi H, Teramoto A, Matsumoto K, Yamada S (2001) Histological and genetic diagnosis of gliomatosis cerebri: case report. J Neurooncol 52:237–240CrossRefPubMed Yamada SM, Hayashi Y, Takahashi H, Teramoto A, Matsumoto K, Yamada S (2001) Histological and genetic diagnosis of gliomatosis cerebri: case report. J Neurooncol 52:237–240CrossRefPubMed
60.
Zurück zum Zitat Yamaguchi F, Saya H, Bruner JM, Morrison RS (1994) Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91:484–488PubMed Yamaguchi F, Saya H, Bruner JM, Morrison RS (1994) Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91:484–488PubMed
61.
Zurück zum Zitat Ylagan LR, Quinn B (1997) CD44 expression in astrocytic tumors. Mod Pathol 10:1239–1246PubMed Ylagan LR, Quinn B (1997) CD44 expression in astrocytic tumors. Mod Pathol 10:1239–1246PubMed
Metadaten
Titel
Molecular genetic alterations in gliomatosis cerebri: What can we learn about the origin and course of the disease?
verfasst von
Christian Mawrin
Publikationsdatum
01.12.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 6/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1083-8

Weitere Artikel der Ausgabe 6/2005

Acta Neuropathologica 6/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.